Rayonier Advanced Materials enters the back half of June with a striking divergence: the stock rallied 12% on the week while options traders flipped sharply defensive — a tension that deserves attention before the August earnings print.
The most striking data point this week is in options. The put/call ratio jumped to 1.70 on Monday, more than four standard deviations above its 20-day average of 1.11 — the largest single-day spike in recent history and a reading that sits well into the upper half of the 52-week range. That kind of demand for downside protection, arriving on the same day the stock gave back 1.3%, suggests some participants are hedging against the week's gains rather than chasing the rally.
Short interest reinforces the cautious tone, though the borrow market itself is far from stressed. Shorts have rebuilt meaningfully — up nearly 19% over the past week and almost 30% over the past month, bringing the position to 6.2% of the free float. That is a real and rising bet against the stock. But availability runs at roughly 1,776%, meaning there are far more shares available to borrow than are currently borrowed; the lending pool is loose, cost to borrow is just under 0.5%, and neither metric suggests any squeeze pressure is building. Shorts can add without friction. The short score has edged up from around 43 to 46.9 since June 8, tracking the week's positioning shift, though it ranks only in the 16th percentile of the ORTEX universe — modest in absolute terms.
The Street picture is thin but not hostile. The sole active analyst coverage comes from RBC Capital, which raised its target to $14 in early March — before the analyst data went stale. At $8.96, the stock trades at a meaningful discount to that figure, implying the market remains unconvinced. The bull case centres on USMCA-compliant product advantages, a recovery in ethers and acetate markets, and a weaker dollar adding roughly $10 million to the financial outlook. Bears point to ongoing High-Yield Pulp weakness — Adjusted EBITDA running below forecasts — and the risk of extended acetate destocking into a Chinese market facing oversupply. The EV/EBITDA multiple has compressed over the past month, consistent with the bear thesis gaining incremental weight. Factor scores are unremarkable across the board, with the short score rank and dividend score both in the bottom third of peers.
The institutional register offers one genuinely interesting thread. Three holders — AIP LLC, Maple Rock Capital Partners, and Vanguard Capital Management — each appear to have initiated or substantially built their positions in the most recent reporting period, collectively adding millions of shares. Condire Investors remains the largest holder at 9.4% with no recent change. That mix of new entrants alongside a stable anchor holder suggests the register is in flux, though the positions are reported with a lag and may not reflect post-rally adjustments.
The next scheduled event is the Q1 results on August 4. The last print delivered a single-day move of just over 9%, with a five-day follow-through of roughly 4%. Whether the stock's 12% week holds into that release — and whether the options market's defensive posture proves prescient or fades — is the question the next six weeks will answer.
See the live data behind this article on ORTEX.
Open RYAM on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
